Clinuvel Pharmaceuticals Limited Price Chart
Clinuvel Pharmaceuticals Limited UR9.MU Financial and Trading Overview
| Clinuvel Pharmaceuticals Limited stock price | 9.3 EUR |
| Previous Close | 11.63 EUR |
| Open | 11.63 EUR |
| Bid | 11.56 EUR x 0 |
| Ask | 11.66 EUR x 0 |
| Day's Range | 11.63 - 11.63 EUR |
| 52 Week Range | 9.35 - 18.29 EUR |
| Volume | 20 EUR |
| Avg. Volume | 19 EUR |
| Market Cap | 1.75B EUR |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
UR9.MU Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Clinuvel Pharmaceuticals Limited Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 18.29 EUR |
| 52 Week Low | 9.35 EUR |
| 50-Day Moving Average | 11.86 EUR |
| 200-Day Moving Average | 13.09 EUR |
UR9.MU Share Statistics
| Avg. Volume (3 month) | 19 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | N/A |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | N/A |
| Most Recent Quarter (mrq) | N/A |
| Next Fiscal Year End | N/A |
Profitability
| Profit Margin | N/A |
| Operating Margin (ttm) | N/A |
| Gross Margin | N/A |
| EBITDA Margin | N/A |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Q&A For Clinuvel Pharmaceuticals Limited Stock
What is a current UR9.MU stock price?
Clinuvel Pharmaceuticals Limited UR9.MU stock price today per share is 9.3 EUR.
How to purchase Clinuvel Pharmaceuticals Limited stock?
You can buy UR9.MU shares on the Munich exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Clinuvel Pharmaceuticals Limited?
The stock symbol or ticker of Clinuvel Pharmaceuticals Limited is UR9.MU.
How many shares does Clinuvel Pharmaceuticals Limited have in circulation?
The max supply of Clinuvel Pharmaceuticals Limited shares is 150.92M.
What is Clinuvel Pharmaceuticals Limited Price to Earnings Ratio (PE Ratio)?
Clinuvel Pharmaceuticals Limited PE Ratio is now.
What was Clinuvel Pharmaceuticals Limited earnings per share over the trailing 12 months (TTM)?
Clinuvel Pharmaceuticals Limited EPS is 0 EUR over the trailing 12 months.